Table 2.
Higher-valent pediatric combination vaccines and the timeline included in the NIPs in selected countries
| Category | U.S. | U.K. | Germany | Singapore | Malaysia | Brazil | Cambodia | China |
|---|---|---|---|---|---|---|---|---|
| Tetravalent vaccines | MMR (2006) | DTaP-IPV (2004) | MMR (2004) | – | – | MMR (2013) | – | – |
| DTaP-IPV (2008) | DTaP-IPV (2006) | |||||||
| Pentavalent vaccines | DTaP-HepB-IPV (2003) | – | – | DTaP-IPV-Hib (2016) | – | DTwP-Hib-HepB (2012) | DTwP-Hib-HepB (2005) | – |
| DTaP-IPV-Hib (2008) | ||||||||
| Hexavalent vaccines | DTaP-IPV-Hib-HepB (2019) | DTaP-IPV-Hib-HepB (2017) | DTaP-IPV-Hib-HepB (2000) | – | DTaP-IPV-Hib-HepB (2020) | – | – | – |
– means not applicable
MMR Measles, mumps, and rubella; DTaP-IPV Diphtheria, tetanus, acellular pertussis, and polio; DTaP-HepB-IPV Diphtheria, tetanus, acellular pertussis, hepatitis B, and polio; DTaP-IPV-Hib Diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b; DTwP-Hib-HepB Diphtheria, tetanus, whole cell pertussis, Haemophilus influenzae type b, and hepatitis B; DTaP-IPV-Hib Diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b; DTaP-IPV-Hib-HepB Diphtheria, tetanus, acellular pertussis, polio, Haemophilus influenzae type b, and hepatitis B